James Liu , Licensed Attorney，holding LL.M.s both from the University of Manchester and one of the top China’s university, as well as a Ph.D. in Management, with twenty years of dedicated experience in the biopharmaceutical and high-tech investment sectors. As a founding practitioner (Founder), I lead the formulation of corporate-wide strategy and development roadmaps, concentrating on core drivers for business growth: effectively integrating critical resources (particularly governmental relations and public policy resources), establishing deep public-private collaborative ecosystems, accurately discerning industry policy trends and driving their translation into execution to ensure corporate compliance and sustained competitive advancement. Leveraging comprehensive expertise spanning R&D, manufacturing, operations management, to investment and financing, I am committed to accelerating the industrialization of innovative achievements and steering organizations toward high-quality, sustainable growth.
刘 James，执业律师，拥有国内外著名高校生物化学本科、双法学硕士及管理学博士学位，于生物医药与高科技投资领域持续深耕二十年。 作为创业实践者（Founder），主导制定企业整体战略与发展路径，聚焦驱动业务增长的核心要素：高效整合关键资源（尤其是政府关系与公共政策资源）、构建深度政企协同生态、精准研判产业政策趋势并推动落地转化，确保企业合规经营与竞争力持续提升。 凭借覆盖研发、生产、管理至投融资的综合经验，致力于促进创新成果产业化，引领企业实现高质量的可持续增长。
With over 30 years of clinical research experience, Gonzalo brings medical, scientific, and business insights to oncology drug development. His understanding of the clinical development – ranging from feasibility assessments, medical monitoring oversight, regulatory strategy, and patient safety enables him to provide valuable guidance to our biopharma partners.
Gonzalo is a board-certified Medical Oncologist with 15+ years of practice in the clinic and as an investigator before leading Global Oncology Medical Teams at the most renowned CROs.
Dominic Jackson is a forward-thinking clinical data professional with deep experience across Central Lab, CRO, and Sponsor environments. He brings a unique, end-to-end perspective on how data can be used more intelligently and creatively in clinical research.
Dominic is particularly interested in how emerging technologies, cross-functional collaboration, and smarter data strategies can unlock new efficiencies and insights. He’s a strong advocate for rethinking traditional approaches and embracing innovation to improve outcomes for both sponsors and patients.
Experienced R&D Director with deep passion for the flavour industry and broad experiences across several multinational companies including Sensient, Kerry and now McCormick Flavour Division. Driven by a dynamic, inspired, entrepreneurial, disruptive, trusting, collaborative, purposeful, excellence-obsessed approach to spark the R&D engine for Business value creation and Company’s growth.
Richard Graham, founder of Mirador Therapeutics and TruTechnologies, is a seasoned leader with extensive experience in business operations, corporate strategy, fundraising, scientific research, and therapeutics development. He excels at aligning corporate strategy with scientific expertise and building partnerships with executives, board members, and investors.
A proven leader in global team management, Rick has successfully driven large-scale R&D programs from concept to completion, consistently achieving ambitious milestones. His work has advanced therapeutics through late-stage development, contributing to the approvals of Erivedge™, Kadcyla™, Kyprolis™, Perjeta™, and Yupelri™.
Alyson Nicks serves as one of two Investigations Branch Supervisory Consumer Safety Officers at the Otay Mesa Port of Entry in the Division of Southwest Imports. She currently serves in the Public Health Service Commissioned Corps in the Pharmacy Category.
Alyson joined the FDA in 2020 as a Consumer Safety Officer at the Otay Mesa Port of Entry. Prior to her FDA career, she worked as a Clinical Pharmacist at the Gallup Indian Health Service and Albuquerque Indian Health Center, where she also served as Pharmacy Residency Director and Acting Facilities Director.
She earned both her Doctor of Pharmacy degree and Bachelor of Science degree from Wilkes University. In her current role, Alyson oversees FDA import operations for Team 7 at the Otay Mesa Port of Entry.
I believe sustainable success is about developing emotionally intelligent resilient leaders who combine a growth mindset with an unwavering commitment to human-centered technology.
Here is what I am doing with my time now:
✍️ Finishing my book, “AI Uncomplicated,”
🎤 Speaking: Responsible AI and Future of Work
👩🏻🏫 Teaching, guest lecturing,
🏛️ Developing Higher Ed. courses & curriculum
Experience:
25+ years in healthcare, business, and consulting + PhD in health informatics from UNT.
